|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.46 USD | -0.57% |
|
+6.35% | -29.15% |
| Dec. 12 | Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating | MT |
| Dec. 12 | Rate Cuts Can't Buy Confidence |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | -747M | 12.2B | 8.36B | -4.71B | -3.56B | ||||
Depreciation & Amortization - CF | 93.54M | 232M | 348M | 621M | 189M | ||||
Depreciation & Amortization, Total | 93.54M | 232M | 348M | 621M | 189M | ||||
(Gain) Loss From Sale Of Asset | 238K | - | - | - | - | ||||
(Gain) Loss on Sale of Investments - (CF) | 10.18M | 54M | 31M | -26M | -43M | ||||
Stock-Based Compensation (CF) | 93.02M | 142M | 226M | 305M | 429M | ||||
Other Operating Activities, Total | - | -318M | -531M | 835M | 60M | ||||
Change In Accounts Receivable | -1.39B | -1.78B | 1.79B | 493M | 534M | ||||
Change In Inventories | -46.53M | -1.39B | 492M | 747M | 83M | ||||
Change In Accounts Payable | 11.88M | 204M | 240M | 13M | -69M | ||||
Change in Unearned Revenues | 3.84B | 2.82B | -4.16B | -2.06B | -439M | ||||
Change In Income Taxes | - | 876M | -828M | 15M | - | ||||
Change In Deferred Taxes | - | - | - | - | - | ||||
Change in Other Net Operating Assets | 155M | 582M | -992M | 653M | -187M | ||||
Cash from Operations | 2.03B | 13.62B | 4.98B | -3.12B | -3B | ||||
Capital Expenditure | -67.45M | -284M | -400M | -707M | -1.05B | ||||
Cash Acquisitions | - | - | - | -85M | - | ||||
Investment in Marketable and Equity Securities, Total | -1.6B | -8.24B | -4.74B | 5.02B | 3B | ||||
Other Investing Activities, Total | - | - | -40M | -23M | - | ||||
Cash from Investing | -1.67B | -8.52B | -5.18B | 4.21B | 1.95B | ||||
Long-Term Debt Issued, Total | - | - | - | - | - | ||||
Total Debt Issued | - | - | - | - | - | ||||
Long-Term Debt Repaid, Total | -6.22M | -140M | -184M | -270M | -10M | ||||
Total Debt Repaid | -6.22M | -140M | -184M | -270M | -10M | ||||
Issuance of Common Stock | 2.04B | 124M | 65M | 46M | 66M | ||||
Repurchase of Common Stock | - | -857M | -3.33B | -1.15B | - | ||||
Issuance of Preferred Stock | - | - | - | - | - | ||||
Repurchase of Preferred Stock | - | - | - | - | - | ||||
Common & Preferred Stock Dividends Paid | - | - | - | - | - | ||||
Common & Preferred Stock Dividends Paid | - | - | - | - | - | ||||
Cash from Financing | 2.03B | -873M | -3.45B | -1.38B | 56M | ||||
Net Change in Cash | 2.39B | 4.22B | -3.64B | -289M | -999M | ||||
Supplemental Items | |||||||||
Cash Interest Paid | 8.53M | 14M | 25M | 39M | 24M | ||||
Cash Income Tax Paid (Refund) | 572K | 480M | 2.73B | -357M | 197M | ||||
Levered Free Cash Flow | 2.19B | 9.29B | 3.67B | -2.38B | -3.09B | ||||
Unlevered Free Cash Flow | 2.2B | 9.3B | 3.69B | -2.36B | -3.07B | ||||
Change In Net Working Capital | -2.55B | -904M | 2.38B | -71M | 174M | ||||
Net Debt Issued / Repaid | -6.22M | -140M | -184M | -270M | -10M |
Select your edition
All financial news and data tailored to specific country editions
















